| 發表論文 | Bibliography
A. Books
- Bow-Wen Chen, Eric Yi-Liang Shen, Skye H. Cheng, Andrew T. Huang, Chapter 14: Liver Tumors in Children. Pediatric Radiation Oncology, 2016 (ISBN-13: 978-1496342867). p.331-46. Editor: Louis S. Constine, Nancy J. Tarbell, Edward C. Halperin
B. Peer-reviewed Journal
Articles (*: corresponding author)
- Sean Hsiang-Ting Chen,
Nai-Ming Cheng, Kang-Shing Fan, Po-Hung Chang, Li-Ang Lee, Shiang-Fu Huang,
Chung-Jan Kang, Eric Yi-Liang Shen, Kai-Ping Chang, Pei-Wen Wu,
Kuang-Hsu Lien, Tuan-Jen Fang, Ann-Joy Cheng, Joseph Tung-Chieh Chang; Refining
M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using
18F-FDG PET/CT: Preliminary Evidence; Clinical Nuclear Medicine; 2026: 51(3),
195-202
- Eric Yi-Liang Shen, Li-Yu Lee, Shu-Hang Ng, Chien-Yu Lin, Hung-Ming Wang, Chia-Hsun
Hsieh, Chih-Hua Yeh, Shiang-Fu Huang, Chung-Jan Kang, Tzu-Chen Yen, Nai-Ming
Cheng, Chun-Ta Liao; Serum Metabolomics for Prognostic Stratification in
Resected Advanced-Stage Oral Cavity Cancer; JAMA Otolaryngology?-Head & Neck
Surgery; 2026: 152(2), 172-181
- Yuan-Hung Kuo, Wei Teng*,
Po-Ting Lin, Yen-Hao Chen, Chung-Wei Su, Eric Yi-Liang Shen, Bing-Shen
Huang, Tsung-Han Wu, Jen-Yu Cheng, Yi-Chung Hsieh, Wei-Ting Chen, Chao-Hung
Hung, Shi-Ming Lin, Chen-Chun Lin, Jing-Houng Wang, Chun-Yen Lin*; Proton Beam
Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular
Carcinoma: A Propensity Score Analysis; Liver International; 2026: 46(1),
e70465
- Tai-Chi Wu, Po-Ting Lin, Wei Teng*, Eric Yi-Liang Shen, Chung-Wei Su, Yi-Chung Hsieh, Wei-Ting Chen, Tsung-Han Wu, Chen-Chun Lin, Shi-Ming Lin, Chun-Yen Lin*; Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab; Cancers; 2025: 17(19), 3157
- Meng-Han Chiang, Chieh-Ni Kuo, Hsien-Ju Lee, Yu-Ying Yu, Eric Yi-Liang Shen, Chih-Yung Chiu; Applications and Development Potential of Nuclear Magnetic Resonance (NMR) Technology in Pediatric Metabolomics; Chemistry (化學); 2025: 83(3), 375-380
- Hung-Han Huang, Joseph T. Chang, Guo-Rung You, Yi-Chen Li, Yi-Fang Huang, Yu-Chen Huang, Eric Yi-Liang Shen, Yin-Ju Chen, Ching-Chi Chiu, Ann-Joy Cheng*; Drug Repurposing Targeting miRNA-mRNA Networks to Mitigate Areca Nut-Induced Head and Neck Cancer; Biomedical Journal; 2025: 100886 (in press)
- Hung-Han Huang, Joseph T. Chang, Guo-Rung You, Yu-Fang Fu, Eric Yi-Liang Shen, Yi-Fang Huang, Chia-Rui Shen, Ann-Joy Cheng*; MiRNA Profiling of Areca Nut-Induced Carcinogenesis in Head and Neck Cancer; Cancers; 2024: 16(21), 3710
- Ching-Rong Lin, Tsung-Min Hung, Eric Yi-Liang Shen, Ann-Joy Cheng, Po-Hung Chang, Shiang-Fu Huang, Chung-Jan Kang, Tuan-Jen Fang, Li-Ang Lee, Chih-Hung Chang, Joseph Tung-Chieh Chang*; Impacts of Employment Status, Partnership, Cancer Type, and Surgical Treatment on Health-Related Quality of Life in Irradiated Head and Neck Cancer Survivors; Cancers; 2024: 16(19), 3366
- Chung-Wei Su, Wei Teng, Eric Yi-Liang Shen, Bing-Shen Huang, Po-Ting Lin, Ming-Mo Hou, Tsung-Han Wu, Din-Li Tsan, Chia-Hsun Hsieh, Ching-Ting Wang, Pei-Mei Chai, Chun-Yen Lin, Shi-Ming Lin, Chen-Chun Lin*; Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma; The Oncologist; 2024: 29(7), e922-e931
- Muhammad Saeed Ahmad*, Novia Minaee, Jose Ivan Serrano-Contreras, Manuja Kaluarachchi, Eric Yi-Liang Shen, Claire Boulange, Sultan Ahmad, Jutarop Phetcharaburanin, Elaine Holmes, Julien Wist, Ahmed Hakem Albaloshi, Tareef Alaama, Zoheir Abdullah Damanhouri, and Samantha Lodge*; Exploring the Interactions between Obesity and Diabetes: Implications for Understanding Metabolic Dysregulation in a Saudi Arabian Adult Population; Journal of Proteome Research; 2024:23(2), 809
- Yu-Chen Chang, Yao-Yu Wu, Din-Li Tsan, Wing-Keen Yap, Kan-Hsin Fan, Joseph Tung-Chieh Chang, Eric Yi-Liang Shen*; Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection; Advances in Radiation Oncology; 2024:9(1), 101302
- Guo-Rung You, Ann-Joy Cheng, Eric Yi-Liang Shen, Kang-Hsing Fan, Yi-Fang Huang, Yu-Chen Huang, Kai-Ping Chang, Joseph T Chang; MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2–GPX2 Molecular Axis in Head–Neck Cancer; Cells; 2023: 12(24), 2853
- Eric Yi-Liang Shen, Mei Ran Abellona U, I Jane Cox, Simon D Taylor-Robinson*; The Role of Mass Spectrometry in Hepatocellular Carcinoma Biomarker Discovery; Metabolites; 2023:13(10), 1059
- Eric Yi-Liang Shen, Tsung-Min Hung, Din-Li Tsan, Nai-Ming Cheng, Chung-Jan Kang, Shiang-Fu Huang, Cheng-Lung Hsu, Chien-Yu Lin, Hung-Ming Wang, Jason Chia-Hsun Hsieh, Ann-Joy Cheng, Kang-Hsing Fan*, Joseph Tung-Chieh Chang*; Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating epstein–barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma; Radiotherapy and Oncology; 2022:177, 1-8
- Ching-Yi Hsieh, Cheng-Hsuan Sung, Eric Yi-Liang Shen, Ying-Chieh Lai, Kuan-Ying Lu, Gigin Lin*; Developing a Method to Estimate the Downstream Metabolite Signals from Hyperpolarized [1-13C] Pyruvate; Sensors; 2022:22 (15), 5480
- Mei Ran Abellona U, Eric Yi-Liang Shen, Caroline Cartlidge, Alzhraa Alkhatib, Mark R Thursz, Imam Waked, Asmaa I Gomaa, Elaine Holmes*, Rohini Sharma, Simon D Taylor-Robinson; Optimised systematic review tool: Application to candidate biomarkers for the diagnosis of hepatocellular carcinoma; Cancer Epidemiology, Biomarkers & Prevention; 2022:31 (7), 1261-1274
- Shinn-Yn Lin, Chi-Cheng Chuang, Din-Li Tsan, Yu-Shin Hung, Chen-Ju Fu, Yi-Liang Shen, Yin-Yin Chiang, Yin-Cheng Huang, Yu-Jen Lu & Chi-Cheng Yang; Maintenance of multi-domain neurocognitive functions in patients with newly-diagnosed primary CNS lymphoma after primary cranial radiotherapy combined with methotrexate-based chemotherapy: A preliminary case-series study; Applied Neuropsychology: Adult; 2022:29 (3), 432-441
- Eric Yi-Liang Shen, Din-Li Tsan, Yin-yin Chiang*, Shinn-Yn Lin*; Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation; International Journal of Hematology; 2022: 115, 363-370
- Munirah Alsaleh, Zoe Leftley, Thomas A. Barbera, Larry K. Koomson, Abigail Zabron, Mary M.E. Crossey, Helen L. Reeves, Matthew Cramp,§ Stephen Ryder, Shaun Greer, Martin Prince, Paiboon Sithithaworn, Mohamed Shariff, Narong Khuntikeo, Watcharin Loilome, Puangrat Yongvanit, Yi-Liang Shen, I. Jane Cox, Roger Williams, Christopher A. Wadsworth, Elaine Holmes, Kathryn Nash, and Simon D. Taylor-Robinson∗; Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort; Journal of clinical and experimental hepatology; 2020: 10(1), 17–29
- Munirah Alsaleh, Thomas A Barbera, Helen L Reeves, Matthew E Cramp, Stephen Ryder, Hani Gabra, Kathryn Nash, Yi-Liang Shen, Elaine Holmes, Roger Williams, Simon D Taylor-Robinson*; Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population; Hepatic Medicine: Evidence and Research; 2019:11, 47–67
- Obinna Ositadimma Oleribe*, Okey Nwanyanwu, Eric Yi-Liang Shen, Simon D Taylor-Robinson; Revisiting public health programming in Nigeria: challenges and solutions; International Journal of General Medicine; 2019:12, 161–166
- Yolanda D. Tseng, David J. Cutter, John P. Plastaras, Rahul R. Parikh, Oren Cahlon, Michael D. Chuong, Katerina Dedeckova, Mohammad K. Khan, Shinn-Yn Lin, Lisa A. McGee, Eric Yi-Liang Shen, MD, Stephanie Terezakis, Shahed N. Badiyan, Youlia M. Kirova, Richard T. Hoppe, Nancy P. Mendenhall, Mark Pankuch, Stella Flampouri, Umberto Ricardi, Bradford S. Hoppe*; Evidence-Based Review on the Utilization of Proton Therapy in Lymphoma from the Particle Therapy Cooperative Group Lymphoma Subcommittee; International Journal of Radiation Oncology, Biology, Physics; 2017:99(4), 825-842.
- Ping-Fang Tsai, Chi-Cheng Yang, Chi-Cheng Chuang, Ting-Yi Huang, Yi-Ming Wu, Ping-Ching Pai, Chen-Kan Tseng, Tung-Ho Wu, Yi-Liang Shen, and Shinn-Yn Lin*; Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study; Radiation Oncology; 2015: 10, 253
- Wei-Heng Kao, Yi-Liang Shen, Ji-Hong Hong*; What are the Potential Benefits of Using Proton Therapy in Taiwanese Cancer Patients? Biomedical Journal; 2015:38(5),391-8
- Yi-Liang Shen, Shinn-Yn Lin, Ji-Hong Hong, Ping-Ching Pai, Chien-Yu Lin, Chen-Kan Tseng, Ngan-Ming Tsang*; Body weight loss ≥5% during radiotherapy confers a Better overall survival in NPC patients with pretreatment BMI≥25; Therapeutic Radiology and Oncology; 2012:19(3), 167-179
A. Presentations
- Partnership in Pancreatic Cancer Care: Advanced Proton Therapy; Proton Therapy Clinical Sharing Session, HMI Medical, Malaysia; March 2026; invited talk
- Serum Metabolomics for Prognostic Stratification in Resected Advanced-Stage Oral Cavity Cancer; Cancer Center, CGMH; February 2026; invited talk
- Proton therapy for unresectable pancreatic cancer; Sumitomo Proton Conference 2025; Taiwan; July 2025; invited talk
- Advancing abdominal cancer care: The synergy of radiation therapy and systemic therapies; HKSBRT study group—annual scientific meeting 2025; Hong Kong, China; April 2025; invited talk
- Comparison of Taste Function in Head and Neck Cancer Patients Receiving IMPT vs IMRT; PTCOG 2024; Singapore; June 2024; oral presentation
- Advancing Global Health: International Partnership in Healthcare and Academia; APHM International Healthcare Conference 2024; Kuala Lumpur; June 2024; invited talk
- Prognostic significance of lymphocyte ratio in patients under trimodality therapy for bladder cancer; ESTRO 2024; Glasgow, UK; May 2024; poster
- Particle therapy for locally advanced pancreatic cancer; Central Taiwan Pancreatic Cancer Forum 2024; Taichung, Taiwan; May 2024; invited talk
- Particle therapy for locally advanced pancreatic cancer; Department of Medical Imaging & intervention, CGMH; May 2024; invited talk
- Metabolomic profiling for guiding personalised immunotherapy of HCC; Healthy Aging Research Center, Chang Gung University; October 2023; invited talk
- Predicting distant metastasis: intensifying systemic therapy? (NPC); Cancer Center, CGMH; December 2022; invited talk
- Short-course radiotherapy for rectal cancer; Next Generation Alliance, Taichung, Taiwan; June 2022; invited talk
- Application of metabolomics to clinical oncology; Department of Medical Research & Development, CGMH; March 2021; invited talk
- Investigating metabolic profiles of HCC via DESI-MSI; Healthy Aging Research Center, Chang Gung University; December 2020; invited talk
- Discovery and validation of plasma acylcarnitines for the early diagnosis of hepatocellular carcinoma; AACR Annual Meeting 2019; Atlanta, USA; March 2019; poster
- Application of metabolic phenotyping to biomarker discovery in hepatocellular carcinoma; the 12th annual conference of the International Liver Cancer Association (ILCA); London; September 2018; poster
- Discovering HCC biomarkers via targeted metabonomics—carnitine and acylcarnitines; the 4th Annual postgraduate Symposium; Cork, Ireland; October, 2017; poster (Best Poster Awards)
- Late Vaginal Recurrence in Carcinoma of Cervix Primarily Treated by Radiation Therapy: The Efficacy and Toxicities of Reirradiation; the 57th Annual Meeting of the American Society for Radiation Oncology (ASTRO); San Antonio, USA; October 2015; poster
- Can The Contralateral Lower Neck Be Spared From Postoperative Radiotherapy For N0-1 Oral Tongue Cancer?; the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO); Atlanta, USA; September 2013; poster
- Body Weight Loss ≥5% During Radiotherapy Confers A Better Overall Survival In NPC Patients With Pretreatment BMI≥25; the 17th Taiwan Joint Cancer Conference; Taipei, Taiwan; April 2012; poster & oral presentation (Honourable mention)
|
